MedTrace Logo

Effects of Oncological Treatment During Pregnancy on Mother and Child

NCT00330447 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2024-03-06

No results posted yet for this study

Summary

The researchers aim to investigate the outcome (overall survival) of mothers who are diagnosed and/or treated for cancer during pregnancy. Furthermore they want to test the hypothesis that children who were exposed to cancer or cancer treatment (cytotoxic drugs, radiation therapy, targeted therapy,...) develop normally (neurologic and cardiologic examination).

Conditions

Sponsors & Collaborators

  • The Netherlands Cancer Institute

    collaborator OTHER

  • Erasmus Medical Center

    collaborator OTHER

  • San Gerardo Hospital

    collaborator OTHER

  • Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

    collaborator OTHER

  • Charles University, Czech Republic

    collaborator OTHER

  • University Hospital, Gasthuisberg

    lead OTHER

Principal Investigators

  • Amant Frederic, MD PhD · KULeuven, Belgium

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2025-04-30
Completion
2032-12-31

Countries

  • United States
  • Argentina
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • France
  • Germany
  • Greece
  • Italy
  • Mexico
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Sweden
  • Tunisia
  • Turkey (Türkiye)
  • Ukraine

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00330447 on ClinicalTrials.gov